Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 6, 2009, Pages 1349-1354

  Bousquet, Philippe Jean ^a,b   Combescure, Christophe ^b   Klossek, Jean Michel ^c   Daurès, Jean Pierre ^b   Bousquet, Jean ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b Groupe Hospitalo Universtaire Caremeau   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Allergic rhinitis; Allergic Rhinitis and Its Impact on Asthma; pragmatic cluster randomized clinical trial; visual analog scale

Indexed keywords

ADULT; ALLERGIC RHINITIS; ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA; ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RANDOMIZATION; RECEIVER OPERATING CHARACTERISTIC; RHINITIS TOTAL SYMPTOM SCORE; RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; RHINORRHEA; SCORING SYSTEM; SNEEZING; SYMPTOM; TREATMENT OUTCOME; VISUAL ANALOG SCALE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HAY FEVER; IMMUNOLOGY; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PERENNIAL RHINITIS; POLLEN; RANDOMIZED CONTROLLED TRIAL;

ANTIALLERGIC AGENT;

ADULT; ANTI-ALLERGIC AGENTS; FEMALE; HUMANS; MALE; PAIN MEASUREMENT; POLLEN; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 67649210686     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.02.033     Document Type: Article

References (47)

1. Ryan D., van Weel C., Bousquet J., Toskala E., Ahlstedt S., Palkonen S., et al. Primary care: the cornerstone of diagnosis of allergic rhinitis. Allergy 63 (2008) 981-989
2. van Weel C. General practitioners' central role in management of asthma and allergic rhinitis. Allergy 63 (2008) 1005-1007
3. Simola M., and Malmberg H. Sensation of nasal airflow compared with nasal airway resistance in patients with rhinitis. Clin Otolaryngol 22 (1997) 260-262
4. Bousquet J., Lund V.J., Van Cauwenberge P., Bremard-Oury C., Mounedji N., Stevens M.T., et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy 58 (2003) 733-741
5. Numminen J., Ahtinen M., Huhtala H., and Rautiainen M. Comparison of rhinometric measurements methods in intranasal pathology. Rhinology 41 (2003) 65-68
6. Senti G., Vavricka B.M., Graf N., Johansen P., Wuthrich B., and Kundig T.M. Evaluation of visual analog scales for the assessment of symptom severity in allergic rhinoconjunctivitis. Ann Allergy Asthma Immunol 98 (2007) 134-138
7. Spector S.L., Nicklas R.A., Chapman J.A., Bernstein I.L., Berger W.E., Blessing-Moore J., et al. Symptom severity assessment of allergic rhinitis: part 1. Ann Allergy Asthma Immunol 91 (2003) 105-114
8. Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey. Treat Respir Med 4 (2005) 439-446
9. Bousquet J., Van Cauwenberge P., and Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108 suppl (2001) S147-S334
10. Bousquet P.J., Combescure C., Neukirch F., Klossek J.M., Mechin H., Daures J.P., et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 62 (2007) 367-372
11. Van Cauwenberge P., and Juniper E.F. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy 30 (2000) 891-899
12. Terreehorst I., Hak E., Oosting A.J., Tempels-Pavlica Z., de Monchy J.G., Bruijnzeel-Koomen C.A., et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med 349 (2003) 237-246
13. Dokic D., Schnitker J., Narkus A., Cromwell O., and Frank E. Clinical effects of specific immunotherapy: a two-year double-blind, placebo-controlled study with a one year follow-up. Prilozi 26 (2005) 113-129
14. Leynaert B., Neukirch C., Liard R., Bousquet J., and Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 162 (2000) 1391-1396
15. Juniper E.F. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 99 suppl (1997) S742-S749
16. Roberts G., Hurley C., and Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J Allergy Clin Immunol 111 (2003) 491-497
17. Bachert C., Bousquet J., Canonica G.W., Durham S.R., Klimek L., Mullol J., et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 114 (2004) 838-844
18. International Rhinitis Management Working Group. International Consensus Report on Diagnosis and Management of Rhinitis. Allergy 49 (1994) 1-34
19. Bousquet J., VanCauwenberge P., and Khaltaev N. Executive Summary of the Workshop Report 7-10, December 1999, Geneva, Switzerland. Allergy 57 (2002) 841-855
20. Juniper E.F., Thompson A.K., Ferrie P.J., and Roberts J.N. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 104 (1999) 364-369
21. Juniper E.F. Quality of life questionnaires: does statistically significant = clinically important?. J Allergy Clin Immunol 102 (1998) 16-17
22. Ciprandi G., Canonica W.G., Grosclaude M., Ostinelli J., Brazzola G.G., and Bousquet J. Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis. Allergy 57 (2002) 586-591
23. Fokkens W.J., Jogi R., Reinartz S., Sidorenko I., Sitkauskiene B., van Oene C., et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 62 (2007) 1078-1084
24. Kaiser H.B., Naclerio R.M., Given J., Toler T.N., Ellsworth A., and Philpot E.E. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 119 (2007) 1430-1437
25. Vasar M., Houle P.A., Douglass J.A., Meltzer E.O., Silvey M., Wu W., et al. Fluticasone furoate nasal spray: effective monotherapy for symptoms of perennial allergic rhinitis in adults/adolescents. Allergy Asthma Proc 29 (2008) 313-321
26. Banov C.H., Woehler T.R., LaForce C.F., Pearlman D.S., Blumenthal M.N., Morgan W.F., et al. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis. Ann Allergy 73 (1994) 240-246
27. Spector S., Bronsky E., Chervinsky P., Lotner G., Koepke J., Selner J., et al. Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis. Ann Allergy 64 (1990) 300-305
28. Day J., and Carrillo T. Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis. J Allergy Clin Immunol 102 (1998) 902-908
29. Stern M.A., Wade A.G., Ridout S.M., and Cambell L.M. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine. Ann Allergy Asthma Immunol 81 (1998) 354-358
30. McNeil B.J., and Hanley J.A. Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med Decis Making 4 (1984) 137-150
31. Drummond C., and Holte R. What ROC curves can't do (and cost curves can). In: ROC analysis in artificial intelligence. First international workshop. Valencia, Spain: ROCAI; (2004) 19-26
32. Bousquet J., Bieber T., Fokkens W., Humbert M., Kowalski M.L., Niggemann B., et al. Consensus statements, evidence-based medicine and guidelines in allergic diseases. Allergy 63 (2008) 1-4
33. Bousquet J., Khaltaev N., Cruz A., Denburg J., Fokkens W., Weel C.V., et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63 suppl (2008) 8-160
34. Pradalier A., Neukirch C., Dreyfus I., and Devillier P. Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis. Allergy 62 (2007) 1331-1334
35. Berger W.E., Schenkel E.J., and Mansfield L.E. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Ann Allergy Asthma Immunol 89 (2002) 485-491
36. Baena-Cagnani C.E., Berger W.E., DuBuske L.M., Gurne S.E., Stryszak P., Lorber R., et al. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 130 (2003) 307-313
37. Meltzer E.O., Jalowayski A.A., Vogt K., Iezzoni D., and Harris A.G. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial. Ann Allergy Asthma Immunol 96 (2006) 363-368
38. de Blay F., Zana H., Offner M., Verot A., Velten M., and Pauli G. Receiver operating characteristic analysis: a useful method for a comparison of the clinical relevance of two in vitro IgE tests. J Allergy Clin Immunol 92 (1993) 255-263
39. Matricardi P.M., Nisini R., Biselli R., and D'Amelio R. Evaluation of the overall degree of sensitization to airborne allergens by a single serologic test: implications for epidemiologic studies of allergy. J Allergy Clin Immunol 93 (1994) 68-79
40. Weintraub J.M., Sparrow D., and Weiss S.T. Receiver operating characteristics curve analysis of cutaneous skin test reactions to predict hay fever and asthma symptoms in the Normative Aging Study. Allergy 56 (2001) 243-246
41. Beeh K.M., Kornmann O., Beier J., Ksoll M., and Buhl R. Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med 98 (2004) 591-597
42. Nathan R.A., Sorkness C.A., Kosinski M., Schatz M., Li J.T., Marcus P., et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113 (2004) 59-65
43. Wewers M.E., and Lowe N.K. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13 (1990) 227-236
44. Langley G.B., and Sheppeard H. The visual analogue scale: its use in pain measurement. Rheumatol Int 5 (1985) 145-148
45. Williamson A., and Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs 14 (2005) 798-804
46. Bousquet J., Zuberbier T., and Mullol J. ACCEPT-1 Study Group icwGL. Improvement in disease-specific quality of life and reduced symptom burden measured with a visual analogue scale in subjects with intermittent allergic rhinitis treated with desloratadine. Allergy 63 suppl 88 (2008) 633
47. Bousquet J. del-Carpio J. group A-S. Improvement in disease-specific quality of life and reduced symptom burden measured with a visual analogue scale in subjects with persistent allergic rhinitis treated with desloratadine. In press 2009.